143
Participants
Start Date
April 30, 2013
Primary Completion Date
February 28, 2015
Study Completion Date
February 28, 2015
Gliclazide 80mg OD
Gliclazide 80mg OD (DPP-IV inhibitor) - for 4 weeks duration followed by a 2 week wash-out period.
Sitagliptin 100mg OD
Sitagliptin 100mg OD (sulphonylurea)- for 4 weeks duration followed by a 2 week wash-out period.
NIHR Exeter Clinical Research Facility, Royal Devon & Exeter NHS Foundation Trust, Exeter
University of Exeter
OTHER
Royal Devon and Exeter NHS Foundation Trust
OTHER